| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 06/09/1994 | CA2149883A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | CA2149862A1 Multifunctional neurotrophic factors |
| 06/09/1994 | CA2149763A1 Progenitor b cell stimulating factor |
| 06/09/1994 | CA2149635A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | CA2148929A1 Proteins having glycosyltransferase activity |
| 06/09/1994 | CA2145384A1 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
| 06/08/1994 | EP0600656A2 Strain of streptomyces for producing antiparasitic compounds and processes therewith |
| 06/08/1994 | EP0600627A1 Human Id genes |
| 06/08/1994 | EP0600463A2 Process for producing L-tryptophan, L-tyrosine or L-Phenylalanine |
| 06/08/1994 | EP0600396A2 Intestinal protozoal vaccines |
| 06/08/1994 | EP0600018A1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 06/08/1994 | EP0600009A1 Hepatitis c assay utilizing recombinant antigens to ns1 |
| 06/08/1994 | EP0599978A1 Gene encoding a human beta-casein process for obtaining the protein and use thereof in an infant formula |
| 06/08/1994 | EP0599971A1 Yeast promoter and use thereof |
| 06/08/1994 | EP0599967A1 Arylalkanoic acid resolution |
| 06/08/1994 | EP0599945A1 Process for purposefully modifying the genetic characteristics of ashbya gossypii |
| 06/08/1994 | EP0599913A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
| 06/08/1994 | EP0599859A1 Mammalian pancreatic lipase and variant thereof |
| 06/08/1994 | EP0460041B1 Probes, kits and methods for the detection and differentiation of mycobacteria |
| 06/08/1994 | EP0438554B1 Nitrogenous ambruticines, process for obtaining them and their use |
| 06/08/1994 | EP0425587B1 Process for determining biological activities in a sample and a device for implementing it |
| 06/08/1994 | EP0225887B1 A method and a hybrid promoter for controlling exogenous gene transcription |
| 06/08/1994 | CN1087681A Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 06/08/1994 | CA2110759A1 Process for producing riboflavin |
| 06/07/1994 | US5318908 Adding a water soluble copper compound and agitating by stirring blades |
| 06/07/1994 | US5318905 Stable against alkaline conditions, anionic surfactants; deinking waste newspaper |
| 06/07/1994 | US5318900 Method for producing antiviral protein utilizing E. coli transformant, and gene and E. coli vector used in the method |
| 06/07/1994 | US5318899 Platelet aggregation inhibitors |
| 06/07/1994 | US5318896 In situ expression of expandase gene; ring expansion of adipoyl-6-amino penicillanic acid; cleavage of adipoyl side chain |
| 06/05/1994 | CA2110117A1 Hispidospermidin |
| 06/01/1994 | EP0599822A2 Method of preparation and use for zona pellucida antigens for sterilization and contraception |
| 06/01/1994 | EP0599658A2 Process for production of 6beta, 14alpha-dihydroxy-4-androstene-3, 17-dione |
| 06/01/1994 | EP0599274A1 HER4, a human receptor tyrosine kinase of the epidermal growth factor receptor family |
| 06/01/1994 | EP0599159A2 Alpha-L-rhamnosidase for obtaining rhamnose, process for the preparation and use |
| 06/01/1994 | EP0598840A1 Human calcium channel compositions and methods |
| 06/01/1994 | EP0598839A1 Purine-region dna binding protein |
| 06/01/1994 | EP0598816A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/01/1994 | EP0598806A1 Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants |
| 06/01/1994 | EP0598768A1 Nucleotide sequences coding for ribosome inactivating proteins |
| 06/01/1994 | EP0479912B1 Inhibition of the n-end rule pathway in living cells |
| 06/01/1994 | EP0172865B2 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
| 06/01/1994 | CN1024809C Microorganism having low acetate forming capability and process for production of useful substrate using same |
| 05/31/1994 | US5317089 Monoclonal antibodies against IFN-omega, processes for preparing them and their use in the purification and detection of IFN-omega |
| 05/31/1994 | US5317011 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 05/31/1994 | US5316947 Synthetic isohirudins with improved stability |
| 05/31/1994 | US5316938 Defined media for serum-free tissue culture |
| 05/31/1994 | US5316930 DNA molecules and plant or bacteria cells |
| 05/31/1994 | US5316925 T-cell receptor specific for antigen polypeptides and related polynucleotides |
| 05/31/1994 | US5316924 Pullulanase, methods of producing pullulanase and methods of saccharification of starch using pullulanase |
| 05/31/1994 | US5316923 Synthetic yeast leader peptides |
| 05/31/1994 | US5316920 Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |
| 05/31/1994 | US5316764 Immunization of dogs to form antibodies |
| 05/31/1994 | CA2109767A1 Strain of streptomyces for producing antiparasitic compounds and processes therewith |
| 05/28/1994 | CA2109680A1 Process for production of 6.beta.14.alpha.-dihydroxy-4-androstene-3, 17-dione |
| 05/26/1994 | WO1994011522A2 Vector for the expression of therapy-relevant genes |
| 05/26/1994 | WO1994011518A2 Methods for converting a, ab, and b blood types to o blood type |
| 05/26/1994 | WO1994011517A1 Process for producing l-threonine by fermentation |
| 05/26/1994 | WO1994011513A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | WO1994011512A2 Allergenic proteins and peptides from japanese cedar pollen |
| 05/26/1994 | WO1994011511A1 Biocidal chitin binding proteins |
| 05/26/1994 | WO1994011506A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | WO1994011502A2 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 05/26/1994 | WO1994011501A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM |
| 05/26/1994 | WO1994011499A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 05/26/1994 | WO1994011496A1 Soluble peptides having constrained, secondary conformation in solution and method of making same |
| 05/26/1994 | WO1994011491A1 Process for the separation of solid materials from microorganisms |
| 05/26/1994 | WO1994011402A1 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
| 05/26/1994 | WO1994011384A1 Novel cytokine designated elk ligand |
| 05/26/1994 | WO1994011315A1 Metal accumulation |
| 05/26/1994 | WO1994011029A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 05/26/1994 | WO1994011026A2 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | WO1994011024A1 Composition protective against p. multocida pasteurellosis infection |
| 05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 05/26/1994 | WO1994011020A1 Eck receptor ligands |
| 05/26/1994 | WO1994011007A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | WO1994009134A3 Modified ciliary neurotrophic factors |
| 05/26/1994 | WO1994008002A3 Methods and compositions for controlling translation of hcv proteins |
| 05/26/1994 | WO1994002510A3 Analogs of pth |
| 05/26/1994 | WO1994001558A3 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | CA2149771A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | CA2149641A1 Methods for converting a, ab and b blood types to o blood type |
| 05/26/1994 | CA2149309A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | CA2149046A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | CA2148838A1 Soluble peptides having constrained, secondary conformation in solution and method of making same |
| 05/26/1994 | CA2148829A1 Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis |
| 05/26/1994 | CA2148713A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/26/1994 | CA2148484A1 Novel cytokine designated elk ligand |
| 05/26/1994 | CA2147985A1 Process for the separation of solid materials from microorganisms |
| 05/26/1994 | CA2147122A1 Biocidal chitin binding proteins |
| 05/25/1994 | EP0598009A1 Continuous natamycin production. |
| 05/25/1994 | EP0598000A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 05/25/1994 | EP0597969A1 Process for the production of thermophilic microorganisms in high yield |
| 05/25/1994 | EP0597852A1 Swine pneumonia vaccine and method for the preparation thereof |
| 05/25/1994 | EP0597845A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2 |
| 05/25/1994 | EP0597844A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 05/25/1994 | EP0597843A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |
| 05/25/1994 | EP0597842A1 Metal binding proteins |
| 05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
| 05/25/1994 | EP0252146B1 Nuclear factors associated with transcriptional regulation |